HUMIRA COMPLETE
LIVE

Serial Number

88329274

Owner

AbbVie Biotechnology Ltd

Attorney

Sonali S. Srivastava

First Use Date

Jan 1, 2013

Filing Date

Mar 7, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HUMIRA COMPLETE Trademark

Serial Number: 88329274 • Registration: 6020255

HUMIRA COMPLETE is a trademark filed by AbbVie Biotechnology Ltd on March 7, 2019. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

AbbVie Biotechnology Ltd

Thistle House, 4 Burnaby Street Hamilton
Pembroke HM 11 , BM

Entity Type: 99

Trademark Details

Filing Date

March 7, 2019

Registration Date

March 24, 2020

First Use Anywhere

January 1, 2013

First Use in Commerce

January 1, 2013

Published for Opposition

May 21, 2019

Goods & Services

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof via the internet, digital media and data banks; Providing scientific research information concerning clinical study results and clinical study data by means of interactive web sites; Providing scientific information in the field of epidemiology, disease background, real world evidence, pharmaceuticals and clinical trials; providing scientific information in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof via the internet, digital media and data banks; provision of scientific information concerning epidemiological study results, real world evidence, clinical study results and clinical study data by means of interactive web sites; providing an interactive web site featuring scientific information on clinical studies and clinical study results

Providing health information

Providing a website featuring nondownloadable publications in the nature of brochures, articles and newsletters in the field of health; Educational services, namely, training in the field of immunology, auto-immune diseases, dermatology, rheumatology, gastroenterology and treatments thereof

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 18, 2026 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 18, 2026 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 18, 2026 APRE
TEAS SECTION 8 & 15 RECEIVED
Mar 23, 2026 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 24, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 20, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 19, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 4, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 4, 2020 AITU
USE AMENDMENT FILED
Jan 15, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 15, 2020 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2019 CNSA
ASSIGNED TO EXAMINER
Mar 26, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 25, 2019 NWOS
NEW APPLICATION ENTERED
Mar 11, 2019 NWAP